跳至主要内容
临床试验/NCT04143932
NCT04143932招募中不适用

Multiple Myeloma Patient Registry - Prospective National Multi Center Prospective Study

Turkish Hematology Association1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2020年10月10日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
1,000
试验地点
1
主要终点
Overall Survival

研究概览

简要总结

This is a non-interventional, national, multi center, prospective multiple myeloma registry in Turkey

详细描述

In this study, approximately from 40 centers 1000 patients will be recruited. All patients will be followed-up till the study end.

All the laboratory results, treatment protocols and responses will be recorded and assessed with EORTC Multiple Myeloma Specific Quality of Life Multiple Myeloma Specific (MY-20) and EORTC Quality of Life-C30 questionnaires.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosed as multiple myeloma
  • Patients signed informed consent form
  • Patients received no more then 2 lines of therapy

排除标准

  • Patients below 18 years old

结局指标

主要结局

Overall Survival

时间窗: [Time Frame: 5 Years]

Time from the diagnosis to the death

Progression Free Survival

时间窗: [Time Frame: 5 Years]

Time from the initiation of treatment to the death from any cause or progression

次要结局

未报告次要终点

研究者

发起方
Turkish Hematology Association
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Multiple Myeloma Turkish Prospective Patient Registry | 临床试验